Status:
COMPLETED
Levetiracetam Treatment of Tardive Dyskinesia
Lead Sponsor:
Yale University
Collaborating Sponsors:
UCB Pharma
Conditions:
Tardive Dyskinesia
Eligibility:
All Genders
18-65 years
Phase:
PHASE3
Brief Summary
This is a placebo-controlled study designed to learn if levetiracetam is effective for tardive dyskinesia.
Eligibility Criteria
Inclusion
- meet Glazer Morgenstern criteria for TD -
Exclusion
- none
- \-
Key Trial Info
Start Date :
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT00291213
Last Update
June 6 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Connecticut Mental Health Center
New Haven, Connecticut, United States, 06519